Eton Pharmaceuticals Insider Trades

ETON

Track insider trading activity from Eton Pharmaceuticals executives and directors. See which insiders are buying and selling ETON stock.

Trades Last 12 Months

All Insider Trades for Eton Pharmaceuticals

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Riedel Norbert G Director
Holding Value $1.31M 47,500 shares
Last Trade
Apr 21, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$294k 12,500 shares
$23.54
$27.61
Krempa David Chief Business Officer
Holding Value $17.4M 630,238 shares
Last Trade
Jan 14, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$30.3k 1,942 shares
$15.62
$27.61
Gruber James R. Chief Financial Officer
Holding Value $5.89M 213,420 shares
Last Trade
Jan 14, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$35.5k 2,293 shares
$15.47
$27.61
Holding Value $8.36M 302,928 shares
Last Trade
Jan 12, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$120k 7,757 shares
$15.47
$27.61
Erdogan Trinkaus Ipek Chief Commercial Officer
Holding Value $3.42M 123,878 shares
Last Trade
Jan 12, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$629k 40,655 shares
$15.47
$27.61
Maier Paul V Director
Holding Value $8.12M 294,253 shares
Last Trade
Jan 12, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$120k 7,757 shares
$15.47
$27.61
Holding Value $4.92M 178,086 shares
Last Trade
Jan 12, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$120k 7,757 shares
$15.47
$27.61
Brynjelsen Sean 10% owner, President & CEO
Holding Value $84.1M 3,047,312 shares
Last Trade
Jan 12, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.44M 158,046 shares
$15.47
$27.61
Holding Value $76.5M 2,770,000 shares
Last Trade
Jun 10, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$125k 7,930 shares
$15.82
$27.61
Holding Value $690k 25,000 shares
Last Trade
Jan 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$325k 25,000 shares
$13.00
$27.61
Erdogan Trinkaus Ipek Chief Commercial Officer
Holding Value $0 0 shares
Last Trade
Dec 02, 2024 Sale
$935k 75,000 shares
$12.46
$27.61
Troutman William Wilson CFO And Secretary
Holding Value $18.5M 671,200 shares
Last Trade
Feb 07, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$56.7k 15,000 shares
$3.78
$27.61
Holding Value $54.7M 1,982,000 shares
Last Trade
Apr 12, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$10.6M 1,518,000 shares
$7.00
$27.61
Baum Mark L Director
Holding Value $757k 27,400 shares
Last Trade
Mar 12, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$98.1k 27,400 shares
$3.58
$27.61

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up